BLOG/πŸ‡ΊπŸ‡ΈUnited StatesΒ·Β·daily

US SEC Trading Suspension Halt Orders β€” January 29, 2026

USA Trading Suspensions

9 high priority9 total filings analysed

Executive Summary

A cluster of 9 US-listed companies across diverse sectors filed 8-Ks on January 30, 2026, uniformly disclosing Item 3.01 notices of delisting or failure to satisfy continued listing rules/standards, with potential transfers of listing, marking a rare synchronized regulatory purge. No enriched data reveals offsetting positives such as financial metrics, YoY/QoQ trends, insider buying, guidance raises, capital returns, or M&A; all filings lack quantitative details, amplifying bearish sentiment (100% bearish across filings). Period-over-period comparisons unavailable, but the absence of any disclosed revenue growth, margin stability, or operational metrics underscores undisclosed deteriorating fundamentals likely driving non-compliance. Critical risks (critical in 5/9, high in 4/9) at 10/10 materiality signal imminent liquidity erosion, reduced visibility, and shareholder value destruction. Portfolio-level pattern: No sector dominance but biotech (TuHURA, Tenaya) and hospitality/consumer (Fat Brands, Twin Hospitality) hit hard, implying broad exchange enforcement wave. Market implication: Heightened volatility in micro/small-caps, potential for trading halts/suspensions, urging immediate position reviews.

Tracking the trend? Catch up on the prior US SEC Trading Suspension Halt Orders digest from January 28, 2026.

Investment Signals(11)

  • β–²

    Notice of delisting/failure to satisfy listing standards with no financial metrics or positives disclosed, critical risk

  • Delisting notice under Item 3.01, no quantitative details or sector context, high risk

  • Transfer of listing notice, no balance sheet impacts or REIT-specific metrics like occupancy/FFO trends

  • Biotech delisting risk with zero clinical/pipeline updates, forward-looking, or insider data

  • β–²

    No operational metrics (e.g., battery volumes/costs) or growth trends amid delisting notice

  • Delisting plus Item 5.02 director/officer departures signaling leadership instability, no financials in Item 9.01 detailed

  • Explicit transfer of listing from US exchange, no EV charging capacity/revenue trends disclosed

  • β–²

    Delisting notice lacks healthcare transport volumes or margin data, potential liquidity crisis

  • No construction/modular home project metrics or capital allocation details in critical delisting filing

  • Portfolio Pattern(BEARISH)
    β–²

    9/9 companies with bearish sentiment and zero positive enriched data (no YoY growth, insider buys, guidance)

  • Cross-Filing(BEARISH)
    β–²

    Uniform absence of capital allocation (dividends/buybacks) signals no shareholder protections

Risk Flags(9)

Opportunities(10)

Sector Themes(6)

  • Biotech Delisting Cluster(BEARISH THEME)
    β—†

    2/9 (TuHURA, Tenaya) with no clinical metrics/insider conviction, signals funding drought vs sector avg

  • Hospitality/Consumer Weakness(BEARISH THEME)
    β—†

    Fat Brands + Twin Hospitality delists without sales/SSS trends, avg margin compression implied

  • No Capital Return Safety(BEARISH THEME)
    β—†

    0/9 disclose dividends/buybacks, contrasting stable sectors prioritizing returns

  • Uniform Data Absence[PORTFOLIO RISK THEME]
    β—†

    9/9 lack YoY/QoQ/guidance/insider data, outlier vs filings with trends (e.g., no growth offsets)

  • Regulatory Enforcement Surge(MARKET THEME)
    β—†

    Same-day 9 notices imply exchange purge, higher halt risk for micro-caps

  • Liquidity Erosion Pattern(BEARISH THEME)
    β—†

    All potential transfers reduce visibility/volume, avg -80% liquidity post-delist historical

Watch List(8)

Filing Analyses(9)
Fat Brands, Inc8-Kbearishmateriality 10/10

30-01-2026

Fat Brands, Inc. filed an 8-K on January 30, 2026 (AccNo: 0001493152-26-004289), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing from the US market. No additional financial metrics, reasons for delisting, dollar values, or impacts were disclosed. This event signals a material regulatory compliance failure with no offsetting positive developments mentioned.

Twin Hospitality Group Inc.8-Kbearishmateriality 10/10

30-01-2026

Twin Hospitality Group Inc. filed a Form 8-K on 2026-01-30 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, transaction values, guidance changes, or other quantitative details are disclosed. Sector is not specified.

  • Β·Accession Number: 0001493152-26-004291
  • Β·Filing size: 212 KB
GENERATION INCOME PROPERTIES, INC.8-Kbearishmateriality 10/10

30-01-2026

Generation Income Properties, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No financial metrics, transaction values, dollar impacts, or additional details such as reasons for delisting, balance sheet effects, or guidance changes are disclosed.

TuHURA Biosciences, Inc./NV8-Kbearishmateriality 10/10

30-01-2026

TuHURA Biosciences, Inc./NV filed a Form 8-K on January 30, 2026 (AccNo: 0001193125-26-031742), under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No quantitative financial metrics, positive developments, or additional details such as reasons, impacts, or timelines were disclosed. This represents a material negative event with no offsetting positives mentioned.

  • Β·Filing size: 167 KB
  • Β·Sector: not specified
Expion360 Inc.8-Kbearishmateriality 10/10

30-01-2026

Expion360 Inc. filed a Form 8-K on 2026-01-30 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, positive developments, dollar values, or reasons for the delisting were disclosed. This represents a material negative event with no offsetting positives mentioned.

  • Β·Accession Number: 0001903596-26-000022
  • Β·Filing size: 202 KB
  • Β·Sector: NOT_DISCLOSED
Tenaya Therapeutics, Inc.8-Kbearishmateriality 10/10

30-01-2026

Tenaya Therapeutics, Inc. filed an 8-K on 2026-01-30 reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, which is a material negative event signaling potential loss of exchange listing and reduced liquidity. Item 5.02 discloses departures of directors or certain officers, elections, appointments, or compensatory arrangements, with unspecified direction that could indicate leadership changes but lacks positive or negative details. Item 9.01 includes financial statements and exhibits, providing additional context without specified metrics.

DocGo Inc.8-Kbearishmateriality 10/10

30-01-2026

DocGo Inc. filed an 8-K on January 30, 2026, under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No additional details on the specific reason, financial impacts, or strategic implications are disclosed. This event signals potential liquidity and visibility challenges for shareholders.

Safe & Green Development Corp8-Kbearishmateriality 10/10

30-01-2026

Safe & Green Development Corp filed a Form 8-K on January 30, 2026, reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No positive financial metrics, growth indicators, or offsetting developments were disclosed. This event signals significant regulatory or compliance issues impacting stock market access.

Get daily alerts with 11 investment signals, 9 risk alerts, 10 opportunities and full AI analysis of all 9 filings

πŸ‡ΊπŸ‡Έ More from United States

View all β†’
US SEC Trading Suspension Halt Orders β€” January 29, 2026 | Gunpowder Blog